


Healthcare News Roundup: Interventional Devices
HSMN NewsFeed - 28 Sep 2012
Cardiac Dimensions(R) Initiates European Commercialization of CARILLON(R) Mitral Contour System(R)
Cardiac Dimensions(R) Initiates European Commercialization of CARILLON(R) Mitral Contour System(R)
HSMN NewsFeed - 28 Sep 2012
Boston Scientific Launches Emerge(TM) PTCA Balloon Dilatation Catheter in the U.S.
Boston Scientific Launches Emerge(TM) PTCA Balloon Dilatation Catheter in the U.S.
HSMN NewsFeed - 25 Sep 2012
InspireMD Announces CEO Transition as it Sets Commercialization Plan for Advanced Stent Technology
InspireMD Announces CEO Transition as it Sets Commercialization Plan for Advanced Stent Technology
HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
HSMN NewsFeed - 18 Sep 2012
Aptus Endosystems Receives U.S. FDA Clearance For Thoracic-Length HeliFX Aortic Securement System
Aptus Endosystems Receives U.S. FDA Clearance For Thoracic-Length HeliFX Aortic Securement System
HSMN NewsFeed - 17 Sep 2012
Covidien Expands Device Portfolio for Endovascular Treatment of Peripheral Vascular Disease
Covidien Expands Device Portfolio for Endovascular Treatment of Peripheral Vascular Disease
HSMN NewsFeed - 6 Sep 2012
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
HSMN NewsFeed - 5 Sep 2012
Intact Vascular Announces $15.5 MM Series A Financing and Names Dennis Wahr, M.D. as Chairman
Intact Vascular Announces $15.5 MM Series A Financing and Names Dennis Wahr, M.D. as Chairman
HSMN NewsFeed - 5 Sep 2012
Surefire Medical's Infusion System For Embolization Procedures Receives CE Mark Approval
Surefire Medical's Infusion System For Embolization Procedures Receives CE Mark Approval
HSMN NewsFeed - 20 Aug 2012
Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent
Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent
